ArticleArXiv2025
An Advanced Two-Stage Model with High Sensitivity and Generalizability for Prediction of Hip Fracture Risk Using Multiple Datasets.
Article in ArXiv, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Hip fractures represent a major source of disability, mortality, and healthcare burden in older adults, making early risk assessment essential for effective prevention. However, widely used tools such as the Dual-energy X-ray Absorptiometry (DXA) T-score and Fracture Risk Assessment Tool (FRAX) are limited in sensitivity and often miss individuals who will experience a fracture, particularly those without prior fracture history or with osteopenia. These limitations highlight the need for new predictive approaches that can incorporate both clinical characteristics and imaging features to improve early detection. In this study, we present a novel sequential two-stage model for predicting hip fracture risk, using data from the Osteoporotic Fractures in Men Study (MrOS), the Study of Osteoporotic Fractures (SOF), and the UK Biobank. In Stage 1 of the model (Screening Stage), clinical, demographic, lifestyle, cognitive, and functional factors are used to estimate the baseline risk of hip fracture. In Stage 2 (Imaging Stage) of the model, imaging features from DXA scans are incorporated to further improve the prediction. The model's performance was rigorously evaluated through both internal and external validations, including independent testing in the UK Biobank, demonstrating its adaptability across diverse populations. This stepwise approach improved sensitivity compared to traditional tools like T-score and FRAX, enabling earlier and more accurate detection of individuals at high risk for subsequent hip fracture. By prioritizing early detection, this sequential model reduced missed cases by offering a more cost-effective strategy that reserves imaging for those identified as possibly at high risk in the initial screening evaluation for subsequent personalized fracture risk assessment.
Indexed as
Identifiers
41281219PMC12633154What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.